Home › Researcher directory › Daniel Birnbaum
Daniel Birnbaum
Affiliation : Centre National de la Recherche Scientifique · Inserm · Aix-Marseille Université · Centre de Recherche en Cancérologie de Marseille · Institut Paoli-Calmettes
- 17Publications (affiliation in France)
- 1177Total publications
- 50738Citations
- 114h-index
Research profile
Daniel Birnbaum has 17 indexed publications (2007–2025). Their work appears mainly in “Oncogene”, “BMC Cancer” and “European Journal of Cancer”. Their most cited article, “Genome profiling of ERBB2-amplified breast cancers” (2010), has been cited 167 times. 2 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in Tunisia, Algeria, United States.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Breast Cancer Treatment Studies
- Breast Lesions and Carcinomas
- Cancer Cells and Metastasis
- Acute Myeloid Leukemia Research
- Gene expression and cancer classification
Publications (17)
- Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
- Deregulated gene expression in relation with DNA methylation profiles associated with Estrogen Receptor (ER) status and breast cancer molecular subtypes
- MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
- Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
- Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study
- A genome‐wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells
- Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer
- MARCKS protein overexpression is associated with poor prognosis in male breast cancer
- Inflammatory breast cancer in 210�patients: A retrospective study on epidemiological, anatomo‑clinical features and therapeutic results
- Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value
- MARCKS protein overexpression in inflammatory breast cancer
- Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling
- Integrated Genomic Analysis of Breast Cancers
- Genome profiling of ERBB2-amplified breast cancers
- Loss, mutation and deregulation of L3MBTL4 in breast cancers
- Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin
- Inflammatory breast cancers in Tunisia and France show similar immunophenotypes
Publication venues
- Oncogene × 2
- BMC Cancer × 2
- European Journal of Cancer × 1
- Cells × 1
- Cancer/Radiothérapie × 1
- EMBO Molecular Medicine × 1
Publications per year
- 20251
- 20241
- 20221
- 20211
- 20201
- 20193
- 20181
- 20171
- 20161
- 20141
Collaborations
Partner institutions : Tunis El Manar University · Institut Salah-Azaïz · Tunis University · Faculté de médecine de Tunis · Université Djilali de Sidi Bel Abbès
Co-authors’ countries : Tunisia · Algeria · United States
Co-authors
- François Bertucci
- Pascal Finetti
- Max Chaffanet
- Maroua Manai
- Emmanuelle Charafe‐Jauffret
- Patrice Viens
- Jocelyne D. Jacquemier
- Ismahane Bekhouche
- Mohamed Manaï
- José Adélaı̈de
- Lynda Addou-Klouche
- Stéphane Raynaud
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.